<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <titles>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>Independent Innovator and Repurposing Act</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to advance the public health by encouraging independent innovators to pursue drug repurposing research and develop new treatments and cures by providing appropriate intellectual property protections for those innovations, and for other purposes.</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>Independent Innovator and Repurposing Act</title>
      </item>
    </titles>
    <introducedDate>2014-03-24</introducedDate>
    <notes />
    <calendarNumbers />
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <name>Judiciary Committee</name>
          <type>Standing</type>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2014-03-24T22:37:16Z</date>
            </item>
          </activities>
          <chamber>Senate</chamber>
          <systemCode>ssju00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <sponsors>
      <item>
        <lastName>Blumenthal</lastName>
        <middleName />
        <bioguideId>B001277</bioguideId>
        <firstName>Richard</firstName>
        <byRequestType />
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
        <identifiers>
          <lisID>2076</lisID>
          <bioguideId>B001277</bioguideId>
          <gpoId>8332</gpoId>
        </identifiers>
      </item>
    </sponsors>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Commerce</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Intellectual property</name>
          </item>
          <item>
            <name>Small business</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <originChamber>Senate</originChamber>
    <createDate>2014-03-25T07:32:41Z</createDate>
    <congress>113</congress>
    <cosponsors>
      <item>
        <sponsorshipWithdrawnDate />
        <bioguideId>H000338</bioguideId>
        <fullName>Sen. Hatch, Orrin G. [R-UT]</fullName>
        <lastName>HATCH</lastName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>1351</lisID>
          <gpoId>8314</gpoId>
          <bioguideId>H000338</bioguideId>
        </identifiers>
        <middleName>GRANT</middleName>
        <sponsorshipDate>2014-03-24</sponsorshipDate>
        <firstName>ORRIN</firstName>
      </item>
    </cosponsors>
    <billType>S</billType>
    <billNumber>2150</billNumber>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in Senate</actionDesc>
          <text><![CDATA[<p>Independent Innovator and Repurposing Act - Establishes procedures under which the term of an unexpired patent claiming a method of using a biological product shall be extended for five years from its original expiration date.</p> <p> Requires an application for such an extension to demonstrate that: (1) the patent was issued to an independent innovator, and (2) the owner of record is the independent innovator or a small business (with fewer than 500 employees and which is not affiliated with the holder of the marketing application approved under licensing requirements of the Public Health Service Act for the commercial marketing of such biological product) in which the independent innovator has an ownership interest.</p> <p>Defines &quot;independent innovator&quot; as a person or entity that obtains a method of use patent for a biological product and is not, at the time of invention or patent filing, affiliated with the holder of an approved application for the commercial marketing of the product.</p>]]></text>
          <lastSummaryUpdateDate>2014-06-23T22:15:20Z</lastSummaryUpdateDate>
          <name>Introduced in Senate</name>
          <actionDate>2014-03-24</actionDate>
          <updateDate>2014-03-24T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <actions>
      <item>
        <actionDate>2014-03-24</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionCode>10000</actionCode>
        <type>IntroReferral</type>
        <text>Introduced in Senate</text>
        <actionDate>2014-03-24</actionDate>
        <links />
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
    </actions>
    <relatedBills>
      <item>
        <latestAction>
          <actionDate>2014-04-16</actionDate>
          <text>Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.</text>
        </latestAction>
        <type>HR</type>
        <congress>113</congress>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <number>4287</number>
        <latestTitle>Independent Innovator and Repurposing Act</latestTitle>
      </item>
    </relatedBills>
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <updateDate>2016-10-25T16:29:23Z</updateDate>
    <recordedVotes />
    <cboCostEstimates />
    <latestAction>
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <actionDate>2014-03-24</actionDate>
      <links />
    </latestAction>
    <title>Independent Innovator and Repurposing Act</title>
    <amendments />
    <laws />
    <committeeReports />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

